Bedel Financial Consulting Inc. Acquires New Holdings in Cardinal Health, Inc. (NYSE:CAH)

Bedel Financial Consulting Inc. bought a new stake in Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,683 shares of the company’s stock, valued at approximately $214,000.

Several other large investors have also recently bought and sold shares of the stock. State Street Corp increased its position in shares of Cardinal Health by 4.6% during the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after purchasing an additional 627,253 shares during the period. Geode Capital Management LLC boosted its stake in Cardinal Health by 0.7% during the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock valued at $633,298,000 after buying an additional 42,082 shares in the last quarter. Pacer Advisors Inc. grew its holdings in Cardinal Health by 4.7% during the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock worth $474,203,000 after acquiring an additional 191,568 shares during the period. Charles Schwab Investment Management Inc. raised its position in Cardinal Health by 2.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock worth $162,976,000 after acquiring an additional 33,388 shares in the last quarter. Finally, Two Sigma Advisers LP lifted its holdings in Cardinal Health by 47.9% in the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock valued at $118,197,000 after acquiring an additional 346,362 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Down 2.2 %

NYSE:CAH opened at $126.38 on Wednesday. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $132.84. The firm has a market capitalization of $30.53 billion, a price-to-earnings ratio of 23.58, a PEG ratio of 1.49 and a beta of 0.63. The business’s fifty day moving average price is $125.11 and its 200 day moving average price is $118.51.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Equities analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.60%. Cardinal Health’s payout ratio is 37.69%.

Wall Street Analysts Forecast Growth

CAH has been the topic of several recent research reports. Wells Fargo & Company lifted their price objective on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $130.00 to $144.00 in a research report on Wednesday, January 8th. JPMorgan Chase & Co. increased their price objective on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Morgan Stanley lifted their target price on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a report on Friday, January 31st. Finally, Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price on the stock in a research report on Tuesday, January 7th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus price target of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.